| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -706.53K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NEUP returned -45.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +1.8% |
| 1 year | -45.0% |
| All-time high | $150.60 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NEUP would be worth today ›No. Neuphoria Therapeutics Inc. has not paid a dividend in the past 12 months.
Neuphoria Therapeutics Inc. stock trades on NASDAQ under the ticker symbol NEUP.
Neuphoria Therapeutics Inc. is part of the Healthcare sector.
Neuphoria Therapeutics Inc. has a market cap of 21.35M USD, based on the latest quote.